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Abstract
Acrylic bone cements were developed around 50 years ago for the fixation of hip prostheses during arthroplasty. Over
the intervening years, a series of drawbacks have been disclosed that have fostered intensive research on the development
of novel or alternative formulations to the standard acrylic cements. Here, we will review the development and
characterization of a novel class of cements, the Hydrophilic, partially Degradable and Bioactive Cements (HDBCs), an
example of multifunctional cements. They were developed to have improved biocompatibility and initial fixation to the
prosthesis and to induce the growth of bone on the surface of the cement and within pores generated by the degradation of
the solid component. HDBCs have higher water uptake than typical acrylic cements, leading to press-fitting inside
constrained cavities. They are tougher, albeit less stiff and strong than hydrophobic cements, and their mechanical
properties may be easily adjusted by small changes in composition. Last, the simultaneous bioactive and degradable
character of HDBCs have been shown to allow in vitro growth of calcium phosphates into pores within the bulk of the
cement.
r 2007 Elsevier Ltd. All rights reserved.
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1. Introduction
Acrylic bone cements were used in the late 50s for
fixing hip prostheses during total hip arthroplasty
[1]. They were composed of cold-polymerized
poly(methylmethacrylate) (PMMA), which reached
the final setting in situ and could thus serve as an
elastic buffer, maintaining the prosthesis in place
and transferring the load from the prosthesis to
the bone.
Since then, little has changed in the composition
of commercially available formulations. All of them
are composed of two phases. The solid is composed
of PMMA or copolymers thereof, initiator (benzoyl
peroxide, BPO) and an opacifier (ZrO2 or BaSO4);
the liquid component is methylmethacrylate
(MMA) monomer or a mixture with butyl metha-
crylate, an activator (dimethyl-p-toluidine, DMT)
and a stabilizer to avoid premature polymerization.
Colorant (chlorophyllin) and antibiotics may also
be present in some formulations. These cements are
one of the most traditional classes of biomaterials in
use, and are simultaneously, the object of intensive
research in universities and companies worldwide.
Bone cements are well suited to their function and
have an excellent performance record. Despite
several modifications, proposed as alternatives to
the original formulations, none have been success-
fully introduced in the market. Therefore, acrylic
bone cements are still the gold standard in
arthroplasty.
This does not mean bone cements are free of
drawbacks that limit their performance. On the
contrary, problems such as thermal or chemical
necrosis of the bone, high porosity, low interfacial
strength between cement and bone and between
cement and prosthesis, residual shrinkage stresses,
infection and inflammation, among other complica-
tions, may occur [2,3], ultimately leading to aseptic
loosening of the implant, the major cause of failure
of hip arthroplasties [2,4]. Therefore, the search for
modified acrylic formulations with improved me-
chanical and biological properties and better overall
performance has been keen in recent years. The
alterations to the conventional formulation have
included fiber reinforcement (which was intended to
improve mechanical properties, but presented ser-
ious drawbacks regarding handling), addition of
bioactive fillers (which simultaneously improve
mechanical properties and allow direct bonding to
bone), replacement of radiopaque agents, tough-
ened cements (by the addition of rubber particles
or hydrophilic moieties), development of novel
activators to replace DMT, partially degradable
formulations (developed to improve the drug release
profile of the cements, at the cost of compro-
mised mechanical properties), crosslinked cements
(developed to decrease chain mobility and improve
mechanical properties) and two-solution formula-
tions (as opposed to formulations with one solid
and one liquid component). Accordingly, there are
several review papers dealing with both the perfor-
mance of commercially available cements and the
properties of novel formulations.
Lewis [3] and Saha and Pal [5] reviewed all the
data on mechanical properties of both commercial
and experimental bone cements while Harper and
Bonfield [6] focused on the tensile properties of
commercially available cements. Ku¨hn [7] presented
a complete listing of all commercially available bone
cements in Germany, comparing their composition,
handling and mechanical properties (besides some
other physical properties). Deb [2] and Serbetci and
Hasirci [8] reviewed the latest developments in bone
cement research, presenting the main properties,
and advantages and disadvantages of the alternative
formulations mentioned above. Harper [9] concen-
trated on bioactive cements, which are the major
focus of attention in terms of novel formulations of
bone cements. This set of publications also contains
useful information about the basics of bone
cements, and the reader is directed to them for
more introductory information about the history,
handling and mechanical properties, the behavior of
the interfaces and the occurrence of infections,
among other topics.
The present review covers the in vitro character-
ization of a novel class of acrylic bone cements,
developed mainly in the last 5 years, which has not
been reviewed previously. This formulation is a
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good example of multifunctional cements, that is,
cements with modifications aimed to address several
of the drawbacks at once. This is in contrast to the
formulations mentioned above, which in general
only try to address one or two of the problems
encountered in acrylic bone cements.
2. Composition and curing parameters of
Hydrophilic, partially Degradable and Bioactive
Cements (HDBCs)
HDBCs represent a step forward in bone cement
research and result from a careful examination of all
the previously reported modifications. Their con-
ception is based on a study of the major drawbacks
of commercially available bone cements and of the
modifications in composition that could overcome
such drawbacks. Therefore, they are not ‘‘just
another’’ alternative cement. Instead, they represent
a novel concept in acrylic bone cements, in which
several alternatives are combined in a synergistic
way, achieving better results than any of them
alone. The major modifications in this system are:
(a) hydrophilic behavior—as compared to hydro-
phobic cements, allowing better release of
antibiotics and better stability through the
‘‘press-fitting’’ effect;
(b) gradient modulus—allowing a better transfer of
load to the bone while still maintaining a high
modulus near the prosthesis-cement interface;
(c) degradability—provided by the incorporation of
degradable polymers and enhanced by hydro-
philic character;
(d) bioactivity—provided by the incorporation of
bioactive fillers and enhanced by both hydro-
philic character and degradability.
These four characteristics, if adequately coupled,
can simultaneously improve the cement perfor-
mance and avoid the drawbacks of each individual
modification, as discussed earlier.
HDBCs contain a hydrophilic monomer in the
liquid component, partially replacing MMA in
order to modify the mechanical and swelling
properties of the system. The hydrophilic monomer
used initially—acrylic acid (AA)—was later re-
placed by 2-hydroxyethyl methacrylate (HEMA)
for the reasons explained in Section 5. These
cements also incorporate starch-based polymers
that can degrade in the body and that have already
been studied for a range of biomedical applications.
Most of the work has so far been concentrated on
blends of starch with cellulose acetate (SCA),
because of their good mechanical properties and
handling behavior. Recently, pure gelatinized starch
or starch containing methacrylic groups have been
also used.
The curing parameters were shown to be strongly
affected by the composition. As the hydrophilic
monomers (AA, HEMA) have an enthalpy of
polymerization higher than MMA, they tend to
increase maximum polymerization temperature
(Tmax). In fact, a lower powder-to-liquid monomer
ratio or MMA/AA ratio leads to higher Tmax
[10,11], while setting time (ts) is longer with a lower
solid amount or higher MMA concentration [11]. A
central composite design was employed to study the
curing of HEMA-containing cements and the effects
of activator, inhibitor and initiator of polymeriza-
tion [12]. It was concluded that lower levels of BPO
were needed for obtaining long ts, while for Tmax it
was important to have DMT opposed to the other
two factors (i.e., low amounts of DMT and high
amounts of BPO and hydroquinone, and vice-
versa). These results agree with those published by
Oldfield and Yasuda [13], who stated that at high
concentrations the amine used as the activator of
BPO may have an inhibitory effect on the poly-
merization rate due to the formation of nitroxides.
A simple method to improve the curing para-
meters of acrylic bone cements is the addition of
inert fillers such as ceramic or metal particles or
fibers. For HDBC, however, the addition of glassy
or ceramic fillers did not decrease Tmax [10,14]; on
the other hand, ts and dough time (td) were both
increased with higher filler content. The lack of
effect on Tmax was attributed to SCA itself being
inert with respect to the polymerization. In conven-
tional cements PMMA plays an active role in the
polymerization process, since monomer diffuses
into the polymer particles and a matrix polymeriza-
tion occurs [15]. In this case, replacement of PMMA
by inert particles will decrease the enthalpy of
dissolution and the enthalpy of matrix polymeriza-
tion leading to an observable decrease in Tmax. In
HDBC, the replacement of one inert polymer by
another inert filler will have no appreciable effect on
Tmax. Only small improvements in ts and td were
observed, owing to the higher density and smaller
particle size of the fillers, leading to a lower total
surface area to be wetted by the monomers. Typical
values of curing parameters for HDBCs are shown
in Table 1.
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3. Water uptake and press-fitting effect in confined
environments
The desired hydrophilic character is provided by
a hydrogel-forming monomer. In order to keep the
formulation close to the original one, these mono-
mers were also acrylics, such as AA [10,11,18] or
HEMA [19–21]. They could be incorporated in the
formulation either as a co-monomer together with
MMA or as the only monomer. Because of the
requirement of good mechanical properties both in
dry and wet states, however, mixtures of MMA with
one of the hydrophilic monomers have been
preferred. HEMA is less hydrophilic than AA;
therefore, similar levels of water uptake (WU) were
achieved when HEMA was present in much higher
amounts than AA [22]. In either case,WU increased
with increasing amount of the hydrophilic monomer
in the formulation, and could be adjusted to values
ranging from 20 to 65wt% [10,11,14,18]. AA
additionally made WU pH dependent to the
cements, the highest uptake occurring in general at
pH 7. If a copolymer was formed (MMA/AA or
MMA/HEMA), the water sorption followed fickian
behavior, while the behavior was closer to Case II
sorption if AA alone was used [18]. Fickian
diffusion is more favorable for the intended
applications, since in this case the polymer will
contain a more homogeneous distribution of water
in the bulk. This behavior is similar to that of
commercially available bone cements, which have a
reported diffusion coefficient of 2.3! 10"8 cm2/s
[23], as compared to 1.8! 10"8 cm2/s for HDBC
(unpublished data). However, because of the very
low WU of commercial formulations (usually
lower than 3wt% [23,24]), the data for diffu-
sion coefficients has only minor relevance, while
they are important in determining the evolution
of several properties of HDBCs, as will be shown
later.
In general, experiments for WU are performed in
a free state, where the specimen, immersed in buffer
solution or saline fluid sorbs water and is able to
swell freely. Fig. 1 shows that the evolution of
weight and volume of a specimen allowed to swell
freely follows similar profiles. Although such tests
are easier to perform and can give indications of the
hydrophilic character of materials, they do not
represent accurately the in vivo situation, in which
the cement is constrained by the prosthesis and the
bone. This situation will not only restrict WU,
because of the impossibility of swelling, but will also
create a ‘‘swelling pressure’’ effect [19]: i.e. the
cement will exert a pressure against the walls (bone
and prosthesis) which restricts the swelling of the
material.
When the uptake of water occurs in conditions
simulating those found in vivo, no swelling is
allowed and the equilibrium water content is greatly
reduced, as shown in Fig. 1b. The consequent
pressure exerted by the cement evolves linearly with
time and may grow at a rate of up to 110 kPa/h
(Fig. 1a). This behavior could be adjusted by several
parameters, such as the monomer ratio, presence of
filler, crosslinking, etc. [19]. In contrast, for con-
ventional cements, due to their very low WU, no
differences are seen between free and constrained
swelling; and consequently, no swelling pressure is
observed.
The hydrophilic behavior and consequent swel-
ling pressure were shown to increase the stability of
the cement in early stages of implantation. When
subjected to push-out tests (extraction of a cylind-
rical specimen from metal capsules), commercial
cement performed much worse than the HDBC for-
mulation (Table 2) [19,25]. The increased push-out
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Table 1
Typical curing parameters of HDBCs under two different conditions
Formulation Tmax (1C) ts (min) td (min) Condition Reference
MMA/AA 70–88 4–5 2 ASTM, ISOa [10,11]
MMA/AA, with HA 85–92 6–8.5 1.3–2.5 ASTM, ISO [10]
Commercial cements 55–90 4.5–13.5 1.5–3.5 ASTM, ISO [7]
MMA/AA 112 4 0.3 Modifiedb [14]
MMA/AA, with bioactive glass 114–116 3–4 0.4–1.1 Modified [14]
HEMA 77–96 1–4 – Modified [12]
Palacoss R 107 7 – Modified [14]
aAccording to the conditions in ASTM [16] and ISO [17] standards.
bModified conditions: storage at T ¼ 4 1C, testing at T ¼ 37 1C [14].
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force was attributed not only to the press-fitting
effect but also to the swelling of the HDBC against
any interstices present in the constrained wall,
creating an additional mechanical interlocking.
The improved performance of HDBC in push-out
tests is an indication that the interface would be
stronger in the first days after implantation: the
press-fitting effect would be complementary to
mechanical interlocking and chemical adhesion
and would decrease the risk of micro-motion at
the cement–bone interface. Another mechanism
(bioactivity) would be more relevant in the long
term, as shown below. These phenomena will also
contribute to release of the residual shrinkage
stresses, which always remain at the stem–
cement interface [26] and facilitate the failure of
the cement.
4. Mechanical properties of HDBCs
The mechanical properties of HDBCs were
studied under static, quasistatic and dynamic
conditions; in tensile, compressive and bending
modes; in dry, partially swelled and fully swelled
states; in free and confined conditions [10,11,
14,18,19,28,29]. This wide range of tests was
designed to cover the situations the material might
face in vivo.
In general, the compressive strength of MMA/
AA cements increased with increasing solid content
as the solid content was varied from 30 to 60wt%
[10,18]. On the other hand, compressive modulus
(Ec) did not follow a clear trend. A design of
experiments was applied to study the effect of
parameters such as the amount of solid, particle
size, mole ratio of the monomers, and others on the
mechanical properties. The composition of the
monomer mixture was found to be the most
important factor determining the compressive prop-
erties of HDBCs [11]. In tensile tests, similar
behavior was seen: an increase in ultimate tensile
strength (UTS) with higher solid content, but no
clear influence on the modulus [10,18]. By adjusting
the composition of the formulation, properties
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Fig. 1. (a) Evolution of water uptake (WU) and swelling (dV) in free environments; evolution of swelling pressure with immersion time in
confined environments. (b) Comparison of the water uptake (WU) of one HDBC formulation when immersed in free and confined
environments [19].
Table 2
Typical mechanical and interfacial properties of HDBCs
Formulation Ec (GPa) sc (MPa) Et (GPa) UTS (MPa) Push-out force (kN) Reference
MMA/AA 1.3–2.1 45–98 2.5–3.8 13–29 [10,11,18]
MMA/HEMA 1.6 64 1.3 30 1.3 [19,27]
MMA/AA, with HA 1.8–2.3 56–88 3.2–5.6 6.4–17 [10]
MMA/AA, with bioactive glass 2.0–4.0 58–100 2.1 30 [14]
MMA/HEMA, with bioactive glass 2.4 28 1.5 [19,27]
MMA/HEMA, with clay 1.4 28 [27]
Commercially available cements 1.7–3.2 68–114 1.6–4.1 24–51 [3,6,7]
Palacoss R 2.8 93 0.1 [14,19]
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better than required by the standards could be
achieved.
The decrease in wet mechanical properties of
HDBCs is one of the major drawbacks as compared
to the standard formulations. Bone cements are
required to maintain good mechanical properties
after long periods of implantation. Commercially
available cements, due to their hydrophobic beha-
vior, show only a moderate decrease in compressive
and bending properties after 4 weeks in water at
37 1C [7], and therefore comply well with such
requirements. HDBCs, on the other hand, may
show up to 88% decrease in yield compressive stress
after only 1 week of immersion in a condition
allowing free swelling [11]. The most important
factor that contributes to this decrease in mechan-
ical properties is the hydrophilic character of the
material, controlled by the mole ratio of monomers
[11]. Fig. 2a shows this effect; clearly if high wet
mechanical properties were the only property to
consider, higher amounts of MMA should be used.
However, this would decrease the hydrophilicity of
the formulation and all the advantages arising from
this characteristic. An intermediate value of 2.0 was
considered a good compromise between these
antagonistic requirements. A somewhat different
picture was observed when in vivo conditions were
simulated (Fig. 2b) by restricting the amount
of sorbed water. Here, HDBC formulations were
able to retain approximately 50% of the initial
compressive strength after taking up 10wt% of
water [30], a value that could better represent the
in vivo WU [19].
Tensile modulus and strength decreased after 7
days of water uptake; however, ductility and energy-
to-break increased steadily up to 3 days immersion
[28]. Even after 100 days of immersion, energy to
break was twice that of the dry specimen [28]. The
failure mode changed from a brittle one, with rapid
failure after crack nucleation to a ductile one, with a
rough fracture surface [11]. This change in behavior
is due to the plasticization induced by water, which
produces a cement with low modulus at the inter-
face with the bone, where the cement will take up
water. The opposite interface (with the stem) will be
initially dry, and such a situation will turn the
HDBC into a sort of ‘‘gradient modulus’’ cement.
The high modulus in the inner part of the mantle
will contribute to maintaining the stiffness necessary
to keep the prosthesis in place under a load. The low
modulus at the interface with the bone will decrease
the local contact stresses usual with commercially
available cements, which cause bone resorption and,
ultimately, loosening of the implant [31]. This
behavior is also an advantage over simple low
modulus cements, which have been introduced to
minimize the inadequate load distribution of con-
ventional formulations and high contact stresses
between cement and bone. However, low modulus
cements exhibit shorter fatigue lives [32] and high
creep rates [33], leading to failure of the mantle and
subsidence of the prosthesis.
Creep of HDBC was also influenced by the
composition: the higher the amount of hydrophobic
monomer, the lower the creep rates in wet condi-
tions [11]; the more hydrophobic formulations also
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Fig. 2. Influence of the mole ratio of the monomer mixture MMA/AA (a) and of the level of water uptake (b) on the wet mechanical
properties of HDBC [11].
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showed smaller residual (permanent) deformation in
creep/recovery tests. In free swelling, HDBCs
showed higher creep rates and permanent deforma-
tion than commercially available cements, for the
reasons discussed in the previous paragraph.
Although creep tests under constrained swelling
conditions have not been performed, the different
behaviors of HDBC with more hydrophobic or
more hydrophilic character may be taken as an
indication that in this situation HDBCs would
perform better. Moreover, the formation of an
apatite-like layer due to the addition of glass
particles (see Section 5) increased the creep resis-
tance under bending, showing the reinforcing effect
of such a layer [29].
These results indicate the strong influence of WU
on the mechanical performance of the developed
cements and the need for a correct adjustment of the
hydrophilicity of the formulation in order to
maintain sufficient mechanical properties after
implantation. While important parameters such as
modulus and compressive strength decrease as a
consequence of water sorption, the cements become
tougher and less prone to fragile fracture. A balance
between these antagonistic effects will be essential to
achieve successful long-term performance without
rendering the material too hydrophobic. To some
extent, the addition of inorganic fillers may be used
to compensate for the decrease in stiffness and
strength without compromising the hydrophilic
character.
Bioactive fillers also had an effect on quasistatic
mechanical properties in the dry state. HA, sintered
or not, increased compressive and tensile properties
(Table 2) [10]. The higher the amount of HA, the
higher the moduli when the solid content was as
much to 50wt%. Regarding UTS, sintered HA
gave, in general, better results than the non-sintered
one, while there was no clear trend for compressive
strength. When the filler was a bioactive glass, both
compressive yield strength (sc) and modulus in-
creased monotonically as loading increased up to
30wt% [14]. With either filler, the mechanical
properties are severely affected by WU, once water
can be easily absorbed at the filler–matrix interfaces
[27]. To solve this issue, organophilic clay was
added instead. Such fillers may be exfoliated
(ultimately achieving nanoscale dispersion) and
have a much better interaction with the polymer.
As a result, both compressive and tensile moduli
after swelling increased by about 30% with the
addition of only 2.4wt% of clay [27].
5. Degradation and bioactive behavior of HDBCs
The degradable character of HDBCs is provided
by corn-starch-based polymers, which can degrade
in the body by hydrolysis. This process is catalyzed
by a-amylase, an enzyme present at low concentra-
tions in human serum. The polymer used for the
majority of tests was a blend of starch with cellulose
acetate (SCA), which has already been studied for a
range of biomedical applications, such as scaffolds
for tissue engineering [34,35], systems for drug
delivery [36] and hydrogels [37,38], and has also
been proposed for bone replacement and regenera-
tion applications [39]. While SCA itself degrades
under the action of a-amylase, the presence of
35–40% of acrylic polymers in the cement formula-
tion hinders the access of the enzyme to the starch
particles, resulting in almost no degradation [20]. To
overcome this problem, thermostable a-amylase was
incorporated into the cement. This enzyme with-
stood the polymerization temperature and caused
visible degradation of the cement [20,22]. The
amount of reducing sugars (products of starch
degradation) in solution increased steadily with
degradation time or enzyme concentration, and this
degradation corresponded to the formation of a
connected network of pores and voids (Fig. 3),
which was not present in the material without the
enzyme.
More recently, pure gelatinized starch or starch
modified with methacrylic side groups has also been
used as the solid component of HDBCs [40]. The
main rationale for their use was an increase in the
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Fig. 3. Morphology of the interior of a specimen after enzymatic
degradation. The pores were formed in the volume previously
occupied by the degradable polymer [20]. Specimen containing
SCA and HEMA/a-amylase; powder-to-liquid ratio (PLR) ¼
1.86.
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total amount of starch in the formulation, since a
minimum of 31.2 vol% of the dispersed phase is
required to achieve the percolation threshold [41]
and, therefore, to guarantee full accessibility of the
starch to the enzyme present in circulating fluid. In
this case, there would be no need to add thermo-
stable a-amylase to the formulation, since the
enzyme from the fluid could diffuse through the
polymer more easily. Formulations containing
methacrylated starch (with a degree of substitution
of 1.76) showed, after 4 weeks, four times as much
degradation as similar formulations with SCA
[20,40], without added enzyme.
This behavior is basically restricted to HDBC
systems, since commercially available cements and
most other experimental formulations are inert. A
few formulations contain hydrolitically degradable
polymers [42,43]. HDBCs, however, have the
advantage of degradation being independent of
WU. Therefore, by playing with the composition
of the solid component or with the amount of
incorporated enzyme, one may adjust the degrada-
tion rate and extent without large variations in
the hydrophilic character of the formulation. While
degradation (with the consequent porosity for-
mation) per se is deleterious to the mechanical
properties of the cements [22], its real advantage
is related to bioactive behavior, which is dis-
cussed next.
Regarding bioactivity, two kinds of fillers were
incorporated into the cements: HA [10,14] and
glasses [14,21,22]. It was found that AA inhibits the
formation of a calcium phosphate layer [14], unless
a very reactive glass is used [22] or if the simulated
body fluid (SBF) solution is renewed periodically
[10]. That was the main reason for replacement of
this monomer by HEMA. HEMA did not present
this inhibitory effect, and by choosing appropriate
glasses, a dense layer of calcium phosphate could be
formed in less than 1 week (Fig. 4) [21]. Moreover,
the behavior of glasses was found to be better than
that of HA, in accordance with other reports in the
literature [44,45].
Commercially available cements do not bond to
bone, and this lack of a strong interaction is one of
the main reasons for the aseptic loosening of the
implant. Due to this fact, intensive research has
been devoted to the development of novel formula-
tions that bond strongly to bone. Bioactive cements
[2,8,9] were formulated with HA, glasses or glass-
ceramics, achieving good mechanical properties and
strong bonding to bone. However, they were all
based on inert, hydrophobic matrices, leading to a
need to expose of particles on the surface of the
cement. Accordingly, the bonding occurred only at
the interface. HDBCs, in contrast, are hydrophilic
and partially degradable. Bone, therefore, could
grow not only at the interface, but could also
infiltrate throughout the material, occupying the
pores generated during degradation. Ultimately,
this would lead to a kind of ‘‘bone-reinforced
cement’’, and the amount of the cement–bone
interface should be much greater than in other
systems. Both effects would compensate for the
reduced mechanical properties of HDBC (due to
WU) and generate a bonding to bone much stronger
than with other formulations.
Bioactivity and enzymatic degradation tests were
performed simultaneously in vitro, to check the
aforementioned hypothesis. Calcium phosphate
precipitates were detected inside the pores generated
during degradation [20,46]. This effect is displayed
in Fig. 5, where a pore on the surface of the
specimen is covered by a layer of calcium phosphate
agglomerates. The agglomerates were visible after
the first week of immersion in SBF. The walls
of pores close to the surface were completely
covered by calcium phosphate layers, while in
inner pores the spreading was less extensive. None-
theless, such results demonstrate the potential of
HDBC to induce the growth of bone in the bulk of
the cement mantle. The growing of calcium
phosphate layer on the surface and in the pores
had also positive effects on mechanical properties as
discussed above.
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Fig. 4. Surface morphology of a specimen of HDBC after
immersion in SBF. A dense layer of calcium phosphate
precipitated on the surface [21]. Specimen containing SCA/
bioactive glass (50/50 by weight in the solid component) and
HEMA; PLR ¼ 1.86.
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6. Concluding remarks
The data developed in the last 5 years on HDBCs
have shown this system is a potential alternative to
replace commercially available cements in arthro-
plasties and as bone filling materials. HDBCs are
not simple ‘‘one more’’ alternative to the conven-
tional bone cements. After analyzing the drawbacks
of conventional bone cements and the advantages
and disadvantages of the several alternatives already
developed, HDBCs were designed combining sev-
eral modifications in one system, creating a system
able to compensate for the shortcomings of each
individual modification. These cements are in-
tended, in vivo, to sorb water immediately after
implantation. The sorption would trigger the swel-
ling pressure and press-fitting effect, improving the
stability of the interface; meanwhile, the cement
would gradually change from a ‘‘normal’’ to a
‘‘gradient’’ modulus cement. Water would also
initiate the degradation of starch, catalyzed by the
incorporated thermostable a-amylase, while the
bioactive fillers would favor the growth of new
bone first at the interface and, as degradation
progresses, inside the pores of the degraded cement.
Thus, the final situation would be that of a low
modulus cement reinforced by bone, with a very
large, strong cement–bone interface, thus ensuring
the required strength and toughness for keeping the
prosthesis functional.
The future of bone cement research, in accor-
dance with current trends in biomaterials, rests on
multifunctional systems that are able to interact
with body tissues. In this way, much better overall
performance may be achieved as compared with
inert systems such as the commercially available
cements. As most bone cement research has
concentrated on increasing the cement–bone inter-
action (bioactive cements), other important char-
acteristics have been neglected: compatibility with
body fluids, penetration of bone inside the cement
mantle, better distribution of the load from the
prosthesis to the bone. Only multifunctional ce-
ments may be able to address all these issues
simultaneously. Among this novel class of poly-
meric cements, HDBCs have been shown to be one
of the best alternatives and whose development is
more advanced. Their extensive in vitro character-
ization reviewed here authorizes further steps into
biological tests and in vivo experiments, which
would confirm whether the cement has adequate
properties for the intended applications.
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